Search

Your search keyword '"Khan, Muhammad Shahzeb"' showing total 24 results

Search Constraints

Start Over You searched for: Author "Khan, Muhammad Shahzeb" Remove constraint Author: "Khan, Muhammad Shahzeb" Language undetermined Remove constraint Language: undetermined
24 results on '"Khan, Muhammad Shahzeb"'

Search Results

1. Robustness of outcomes in trials evaluating sodium-glucose co-transporter 2 inhibitors for heart failure

2. Minimal Clinically Important Difference for Six-minute Walk Test in Patients with HFrEF and Iron Deficiency

3. Health Status Improvement with Ferric Carboxymaltose in Heart Failure with Reduced Ejection Fraction and Iron Deficiency

4. Additional file 1 of Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis

5. Trends in prevalence of comorbidities in heart failure clinical trials

6. Prevalence of Multiplicity and Appropriate Adjustments Among Cardiovascular Randomized Clinical Trials Published in Major Medical Journals

7. Additional file 2 of Are patients on oral anticoagulation therapy aware of its effects? A cross-sectional study from Karachi, Pakistan

8. Additional file 1 of Are patients on oral anticoagulation therapy aware of its effects? A cross-sectional study from Karachi, Pakistan

9. Additional file 1 of Cardiovascular implications of COVID-19 versus influenza infection: a review

10. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

11. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

12. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

14. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

15. Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis

16. Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017

17. Mapping 123 million neonatal, infant and child deaths between 2000 and 2017

18. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017

19. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

20. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

21. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

22. Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))

23. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017

24. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

Catalog

Books, media, physical & digital resources